CD59 and neoplasm: Among the mCRPs upregulated upon CTL-mediated immune selection, CD59 had dominant effects on the CDC-resistant phenotype (Fig. 1d); hence, we attempted to elucidate the underlying mechanism responsible for CD59 upregulation in CTL-resistant tumor cells.